These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12240938)

  • 1. Artificial neural network prediction of aerosol deposition in human lungs.
    Nazir J; Barlow DJ; Lawrence MJ; Richardson CJ; Shrubb I
    Pharm Res; 2002 Aug; 19(8):1130-6. PubMed ID: 12240938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial neural network prediction of the patterns of deposition of polydisperse aerosols within human lungs.
    Nazir J; Barlow DJ; Jayne Lawrence M; Shrubb I
    J Pharm Sci; 2005 Sep; 94(9):1986-97. PubMed ID: 16052546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
    Kolanjiyil AV; Kleinstreuer C; Sadikot RT
    Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary and Regional Deposition of Nebulized and Dry Powder Aerosols in Ferrets.
    Kuehl PJ; Chand R; McDonald JD; Hava DL; DeHaan WH
    AAPS PharmSciTech; 2019 Jul; 20(6):242. PubMed ID: 31264190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validating CFD Predictions of Pharmaceutical Aerosol Deposition with In Vivo Data.
    Tian G; Hindle M; Lee S; Longest PW
    Pharm Res; 2015 Oct; 32(10):3170-87. PubMed ID: 25944585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
    Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
    Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung deposition and respirable mass during wet nebulization.
    Sangwan S; Condos R; Smaldone GC
    J Aerosol Med; 2003; 16(4):379-86. PubMed ID: 14977428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional particle size dependent deposition of inhaled aerosols in rats and mice.
    Kuehl PJ; Anderson TL; Candelaria G; Gershman B; Harlin K; Hesterman JY; Holmes T; Hoppin J; Lackas C; Norenberg JP; Yu H; McDonald JD
    Inhal Toxicol; 2012 Jan; 24(1):27-35. PubMed ID: 22145784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of particle size of dry powder mannitol on the lung deposition in healthy volunteers.
    Glover W; Chan HK; Eberl S; Daviskas E; Verschuer J
    Int J Pharm; 2008 Feb; 349(1-2):314-22. PubMed ID: 17904774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods of calculating lung delivery and deposition of aerosol particles.
    Kim CS
    Respir Care; 2000 Jun; 45(6):695-711. PubMed ID: 10894462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled, Parametric, Individualized, 2-D and 3-D Imaging Measurements of Aerosol Deposition in the Respiratory Tract of Asthmatic Human Subjects for Model Validation.
    Fleming J; Conway J; Majoral C; Katz I; Caillibotte G; Pichelin M; Montesantos S; Bennett M
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):432-51. PubMed ID: 25859710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of functional respiratory imaging to characterize the effect of inhalation profile and particle size on lung deposition of inhaled corticosteroid/long-acting β2-agonists delivered via a pressurized metered-dose inhaler.
    Van Holsbeke C; De Backer J; Vos W; Marshall J
    Ther Adv Respir Dis; 2018; 12():1753466618760948. PubMed ID: 29499614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro tests for aerosol deposition. III: effect of inhaler insertion angle on aerosol deposition.
    Delvadia RR; Longest PW; Hindle M; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):145-56. PubMed ID: 23025452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerosol deposition considerations in inhalation therapy.
    Newman SP
    Chest; 1985 Aug; 88(2 Suppl):152S-160S. PubMed ID: 3893925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing lung regions of interest in gamma scintigraphy for assessing inhaled therapeutic aerosol deposition.
    Biddiscombe MF; Meah SN; Underwood SR; Usmani OS
    J Aerosol Med Pulm Drug Deliv; 2011 Jun; 24(3):165-73. PubMed ID: 21453048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry powder aerosol delivery systems: current and future research directions.
    Chan HK
    J Aerosol Med; 2006; 19(1):21-7. PubMed ID: 16551211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurements of electrodynamic effects on the deposition of MDI and DPI aerosols in a replica cast of human oral-pharyngeal-laryngeal airways.
    Ali M; Mazumder MK; Martonen TB
    J Aerosol Med Pulm Drug Deliv; 2009 Mar; 22(1):35-44. PubMed ID: 18800879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micron particle deposition in a tracheobronchial airway model under different breathing conditions.
    Inthavong K; Choi LT; Tu J; Ding S; Thien F
    Med Eng Phys; 2010 Dec; 32(10):1198-212. PubMed ID: 20855226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deposition of Particles in the Alveolar Airways: Inhalation and Breath-Hold with Pharmaceutical Aerosols.
    Khajeh-Hosseini-Dalasm N; Longest PW
    J Aerosol Sci; 2015 Jan; 79():15-30. PubMed ID: 25382867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deposition of coarse particles in cystic fibrosis: model predictions versus experimental results.
    Brown JS; Bennett WD
    J Aerosol Med; 2004; 17(3):239-48. PubMed ID: 15625816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.